Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar Therapy

Inclusion Criteria: 1. An 18 to 85 years old (inclusive) female or male patient 2. Prescribed compound for the treatment of pain, wound healing or surface skin scar by their Principal Investigator 3. Any systemic disease (cardiac, renal, or hepatic) must be well controlled. 4. Has no skin lesions at the site of application of study medication except for wound under treatment 5. Able to provide informed consent Exclusion Criteria: 1. Pregnant or lactating females or women at the child bearing potential not using effective contraception. 2. Use of other topical or transdermal medication. Patients may be withdrawn for a period of 2 weeks from all topical or transdermal medications prior to study initiation. 3. Hypersensitivity to local anesthetic or other ingredients of the compounded creams to be used in a study. 4. Prior reconstruction skin surgery or skin grafts in the area of cream application preventing absorption of cream except for the treatment of surface skin scar 5. Chronic pain conditions not expected to respond to topical pain medication such as deep abdominal pain, or from conditions such as cancer, or gouty arthritis.